Evidence map›Paper›PMID 31299963›Full record

ArticleRespiratory research2019

Dose variability of supplemental oxygen therapy with open patient interfaces based on in vitro measurements using a physiologically realistic upper airway model.

Ira Katz, John Chen, Kelvin Duong, Kaixian Zhu, Marine Pichelin, Georges Caillibotte, Andrew R Martin

Abstract read
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ira KatzMedical R&D, Air Liquide Santé International, Paris Innovation Campus, Les loges-en-Josas, France. ira.katz@airliquide.com.ORCID http://orcid.org/0000-0001-6755-9739
John ChenDepartment of Mechanical Engineering, University of Alberta, Edmonton, Canada.
Kelvin DuongDepartment of Mechanical Engineering, University of Alberta, Edmonton, Canada.
Kaixian ZhuAir Liquide Healthcare, Gentilly, France.
Marine PichelinTechnical Innovation, Air Liquide Santé International, Paris Innovation Campus, Les Loges-en-Josas, France.
Georges CaillibotteTechnical Innovation, Air Liquide Santé International, Paris Innovation Campus, Les Loges-en-Josas, France.
Andrew R MartinDepartment of Mechanical Engineering, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSupplemental oxygen therapy is widely used in hospitals and in the home for chronic care. However, there are several fundamental problems with the application of this therapy such that patients are often exposed to arterial oxygen concentrations outside of the intended target range. This paper reports volume-averaged tracheal oxygen concentration measurements (FtO2) from in vitro experiments conducted using a physiologically realistic upper airway model. The goal is to provide data to inform a detailed discussion of the delivered oxygen dose.

methodsA baseline FtO2 dataset using a standard, straight adult nasal cannula was established by varying tidal volume (V

resultsOxygen concentration measured at the trachea varied by as much as 60% (i.e. from 30.2 to 48.0% of absolute oxygen concentration) for the same oxygen supply flow rate due to variation in simulated breathing pattern. Among the baseline cases, the chief reasons for variation were 1) the influence of variation in tidal volume leading to variable FiO2 and 2) variation in breathing frequency affecting volume of supplemental oxygen delivered through the breath.

conclusionFor oxygen administration using open patient interfaces there was variability in the concentration and quantity of oxygen delivered to the trachea over the large range of scenarios studied. Of primary importance in evaluating the oxygen dose is knowledge of the breathing parameters that determine the average inhalation flow rate relative to the oxygen flow rate. Otherwise, the oxygen dose cannot be determined.

Indexed as

Models, BiologicalHumansLungOxygen Inhalation TherapyRespiratory MechanicsTidal VolumeFacemaskFraction of inspired oxygenNasal cannulaOxygenOxygen therapySupplemental oxygen

Identifiers

PMID31299963
PMCPMC6625031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.